Global Genetic Engineering Drug Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Genetic Engineering Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Genetic Engineering Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Genetic Engineering Drug by Country/Region, 2017, 2022 & 2028

2.2 Genetic Engineering Drug Segment by Type

2.2.1 Monoclonal Antibody

2.2.2 Recombinant Human Erythropoietin

2.2.3 Recombinant Human Interferon

2.2.4 Recombinant Human Growth Hormone

2.2.5 Recombinant Human Insulin

2.3 Genetic Engineering Drug Sales by Type

2.3.1 Global Genetic Engineering Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Genetic Engineering Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Genetic Engineering Drug Sale Price by Type (2017-2022)

2.4 Genetic Engineering Drug Segment by Application

2.4.1 Medicine

2.4.2 Research

2.4.3 Industrial

2.4.4 Agriculture

2.4.5 Other

2.5 Genetic Engineering Drug Sales by Application

2.5.1 Global Genetic Engineering Drug Sale Market Share by Application (2017-2022)

2.5.2 Global Genetic Engineering Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global Genetic Engineering Drug Sale Price by Application (2017-2022)

3 Global Genetic Engineering Drug by Company

3.1 Global Genetic Engineering Drug Breakdown Data by Company

3.1.1 Global Genetic Engineering Drug Annual Sales by Company (2020-2022)

3.1.2 Global Genetic Engineering Drug Sales Market Share by Company (2020-2022)

3.2 Global Genetic Engineering Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Genetic Engineering Drug Revenue by Company (2020-2022)

3.2.2 Global Genetic Engineering Drug Revenue Market Share by Company (2020-2022)

3.3 Global Genetic Engineering Drug Sale Price by Company

3.4 Key Manufacturers Genetic Engineering Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Genetic Engineering Drug Product Location Distribution

3.4.2 Players Genetic Engineering Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Genetic Engineering Drug by Geographic Region

4.1 World Historic Genetic Engineering Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Genetic Engineering Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Genetic Engineering Drug Annual Revenue by Geographic Region

4.2 World Historic Genetic Engineering Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Genetic Engineering Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Genetic Engineering Drug Annual Revenue by Country/Region

4.3 Americas Genetic Engineering Drug Sales Growth

4.4 APAC Genetic Engineering Drug Sales Growth

4.5 Europe Genetic Engineering Drug Sales Growth

4.6 Middle East & Africa Genetic Engineering Drug Sales Growth

5 Americas

5.1 Americas Genetic Engineering Drug Sales by Country

5.1.1 Americas Genetic Engineering Drug Sales by Country (2017-2022)

5.1.2 Americas Genetic Engineering Drug Revenue by Country (2017-2022)

5.2 Americas Genetic Engineering Drug Sales by Type

5.3 Americas Genetic Engineering Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Genetic Engineering Drug Sales by Region

6.1.1 APAC Genetic Engineering Drug Sales by Region (2017-2022)

6.1.2 APAC Genetic Engineering Drug Revenue by Region (2017-2022)

6.2 APAC Genetic Engineering Drug Sales by Type

6.3 APAC Genetic Engineering Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Genetic Engineering Drug by Country

7.1.1 Europe Genetic Engineering Drug Sales by Country (2017-2022)

7.1.2 Europe Genetic Engineering Drug Revenue by Country (2017-2022)

7.2 Europe Genetic Engineering Drug Sales by Type

7.3 Europe Genetic Engineering Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Genetic Engineering Drug by Country

8.1.1 Middle East & Africa Genetic Engineering Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Genetic Engineering Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Genetic Engineering Drug Sales by Type

8.3 Middle East & Africa Genetic Engineering Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Genetic Engineering Drug

10.3 Manufacturing Process Analysis of Genetic Engineering Drug

10.4 Industry Chain Structure of Genetic Engineering Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Genetic Engineering Drug Distributors

11.3 Genetic Engineering Drug Customer

12 World Forecast Review for Genetic Engineering Drug by Geographic Region

12.1 Global Genetic Engineering Drug Market Size Forecast by Region

12.1.1 Global Genetic Engineering Drug Forecast by Region (2023-2028)

12.1.2 Global Genetic Engineering Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Genetic Engineering Drug Forecast by Type

12.7 Global Genetic Engineering Drug Forecast by Application

13 Key Players Analysis

13.1 Shanghai Lansheng Guojian Pharmaceutical

13.1.1 Shanghai Lansheng Guojian Pharmaceutical Company Information

13.1.2 Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Product Offered

13.1.3 Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Shanghai Lansheng Guojian Pharmaceutical Main Business Overview

13.1.5 Shanghai Lansheng Guojian Pharmaceutical Latest Developments

13.2 Biotech Pharmaceutical

13.2.1 Biotech Pharmaceutical Company Information

13.2.2 Biotech Pharmaceutical Genetic Engineering Drug Product Offered

13.2.3 Biotech Pharmaceutical Genetic Engineering Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Biotech Pharmaceutical Main Business Overview

13.2.5 Biotech Pharmaceutical Latest Developments

13.3 Anhui Anke Biotechnology

13.3.1 Anhui Anke Biotechnology Company Information

13.3.2 Anhui Anke Biotechnology Genetic Engineering Drug Product Offered

13.3.3 Anhui Anke Biotechnology Genetic Engineering Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Anhui Anke Biotechnology Main Business Overview

13.3.5 Anhui Anke Biotechnology Latest Developments

13.4 GeneScience Pharmaceuticals

13.4.1 GeneScience Pharmaceuticals Company Information

13.4.2 GeneScience Pharmaceuticals Genetic Engineering Drug Product Offered

13.4.3 GeneScience Pharmaceuticals Genetic Engineering Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 GeneScience Pharmaceuticals Main Business Overview

13.4.5 GeneScience Pharmaceuticals Latest Developments

13.5 Beijing SL Pharmaceutical

13.5.1 Beijing SL Pharmaceutical Company Information

13.5.2 Beijing SL Pharmaceutical Genetic Engineering Drug Product Offered

13.5.3 Beijing SL Pharmaceutical Genetic Engineering Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Beijing SL Pharmaceutical Main Business Overview

13.5.5 Beijing SL Pharmaceutical Latest Developments

13.6 Jiangsu Sihuan Bioengineering

13.6.1 Jiangsu Sihuan Bioengineering Company Information

13.6.2 Jiangsu Sihuan Bioengineering Genetic Engineering Drug Product Offered

13.6.3 Jiangsu Sihuan Bioengineering Genetic Engineering Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Jiangsu Sihuan Bioengineering Main Business Overview

13.6.5 Jiangsu Sihuan Bioengineering Latest Developments

13.7 Shenzhen Neptunus Interlong Bio-Technique

13.7.1 Shenzhen Neptunus Interlong Bio-Technique Company Information

13.7.2 Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Product Offered

13.7.3 Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Shenzhen Neptunus Interlong Bio-Technique Main Business Overview

13.7.5 Shenzhen Neptunus Interlong Bio-Technique Latest Developments

13.8 3SBio

13.8.1 3SBio Company Information

13.8.2 3SBio Genetic Engineering Drug Product Offered

13.8.3 3SBio Genetic Engineering Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 3SBio Main Business Overview

13.8.5 3SBio Latest Developments

13.9 Tonghua Dongbao Pharmaceutical

13.9.1 Tonghua Dongbao Pharmaceutical Company Information

13.9.2 Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Product Offered

13.9.3 Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Tonghua Dongbao Pharmaceutical Main Business Overview

13.9.5 Tonghua Dongbao Pharmaceutical Latest Developments

14 Research Findings and Conclusion

Table 1. Genetic Engineering Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Genetic Engineering Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Monoclonal Antibody

Table 4. Major Players of Recombinant Human Erythropoietin

Table 5. Major Players of Recombinant Human Interferon

Table 6. Major Players of Recombinant Human Growth Hormone

Table 7. Major Players of Recombinant Human Insulin

Table 8. Global Genetic Engineering Drug Sales by Type (2017-2022) & (K Units)

Table 9. Global Genetic Engineering Drug Sales Market Share by Type (2017-2022)

Table 10. Global Genetic Engineering Drug Revenue by Type (2017-2022) & ($ million)

Table 11. Global Genetic Engineering Drug Revenue Market Share by Type (2017-2022)

Table 12. Global Genetic Engineering Drug Sale Price by Type (2017-2022) & (USD/Unit)

Table 13. Global Genetic Engineering Drug Sales by Application (2017-2022) & (K Units)

Table 14. Global Genetic Engineering Drug Sales Market Share by Application (2017-2022)

Table 15. Global Genetic Engineering Drug Revenue by Application (2017-2022)

Table 16. Global Genetic Engineering Drug Revenue Market Share by Application (2017-2022)

Table 17. Global Genetic Engineering Drug Sale Price by Application (2017-2022) & (USD/Unit)

Table 18. Global Genetic Engineering Drug Sales by Company (2020-2022) & (K Units)

Table 19. Global Genetic Engineering Drug Sales Market Share by Company (2020-2022)

Table 20. Global Genetic Engineering Drug Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Genetic Engineering Drug Revenue Market Share by Company (2020-2022)

Table 22. Global Genetic Engineering Drug Sale Price by Company (2020-2022) & (USD/Unit)

Table 23. Key Manufacturers Genetic Engineering Drug Producing Area Distribution and Sales Area

Table 24. Players Genetic Engineering Drug Products Offered

Table 25. Genetic Engineering Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Genetic Engineering Drug Sales by Geographic Region (2017-2022) & (K Units)

Table 29. Global Genetic Engineering Drug Sales Market Share Geographic Region (2017-2022)

Table 30. Global Genetic Engineering Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Genetic Engineering Drug Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Genetic Engineering Drug Sales by Country/Region (2017-2022) & (K Units)

Table 33. Global Genetic Engineering Drug Sales Market Share by Country/Region (2017-2022)

Table 34. Global Genetic Engineering Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Genetic Engineering Drug Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Genetic Engineering Drug Sales by Country (2017-2022) & (K Units)

Table 37. Americas Genetic Engineering Drug Sales Market Share by Country (2017-2022)

Table 38. Americas Genetic Engineering Drug Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Genetic Engineering Drug Revenue Market Share by Country (2017-2022)

Table 40. Americas Genetic Engineering Drug Sales by Type (2017-2022) & (K Units)

Table 41. Americas Genetic Engineering Drug Sales Market Share by Type (2017-2022)

Table 42. Americas Genetic Engineering Drug Sales by Application (2017-2022) & (K Units)

Table 43. Americas Genetic Engineering Drug Sales Market Share by Application (2017-2022)

Table 44. APAC Genetic Engineering Drug Sales by Region (2017-2022) & (K Units)

Table 45. APAC Genetic Engineering Drug Sales Market Share by Region (2017-2022)

Table 46. APAC Genetic Engineering Drug Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Genetic Engineering Drug Revenue Market Share by Region (2017-2022)

Table 48. APAC Genetic Engineering Drug Sales by Type (2017-2022) & (K Units)

Table 49. APAC Genetic Engineering Drug Sales Market Share by Type (2017-2022)

Table 50. APAC Genetic Engineering Drug Sales by Application (2017-2022) & (K Units)

Table 51. APAC Genetic Engineering Drug Sales Market Share by Application (2017-2022)

Table 52. Europe Genetic Engineering Drug Sales by Country (2017-2022) & (K Units)

Table 53. Europe Genetic Engineering Drug Sales Market Share by Country (2017-2022)

Table 54. Europe Genetic Engineering Drug Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Genetic Engineering Drug Revenue Market Share by Country (2017-2022)

Table 56. Europe Genetic Engineering Drug Sales by Type (2017-2022) & (K Units)

Table 57. Europe Genetic Engineering Drug Sales Market Share by Type (2017-2022)

Table 58. Europe Genetic Engineering Drug Sales by Application (2017-2022) & (K Units)

Table 59. Europe Genetic Engineering Drug Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Genetic Engineering Drug Sales by Country (2017-2022) & (K Units)

Table 61. Middle East & Africa Genetic Engineering Drug Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Genetic Engineering Drug Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Genetic Engineering Drug Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Genetic Engineering Drug Sales by Type (2017-2022) & (K Units)

Table 65. Middle East & Africa Genetic Engineering Drug Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Genetic Engineering Drug Sales by Application (2017-2022) & (K Units)

Table 67. Middle East & Africa Genetic Engineering Drug Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Genetic Engineering Drug

Table 69. Key Market Challenges & Risks of Genetic Engineering Drug

Table 70. Key Industry Trends of Genetic Engineering Drug

Table 71. Genetic Engineering Drug Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Genetic Engineering Drug Distributors List

Table 74. Genetic Engineering Drug Customer List

Table 75. Global Genetic Engineering Drug Sales Forecast by Region (2023-2028) & (K Units)

Table 76. Global Genetic Engineering Drug Sales Market Forecast by Region

Table 77. Global Genetic Engineering Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Genetic Engineering Drug Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Genetic Engineering Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 80. Americas Genetic Engineering Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Genetic Engineering Drug Sales Forecast by Region (2023-2028) & (K Units)

Table 82. APAC Genetic Engineering Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Genetic Engineering Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Europe Genetic Engineering Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Genetic Engineering Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 86. Middle East & Africa Genetic Engineering Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Genetic Engineering Drug Sales Forecast by Type (2023-2028) & (K Units)

Table 88. Global Genetic Engineering Drug Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Genetic Engineering Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Genetic Engineering Drug Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Genetic Engineering Drug Sales Forecast by Application (2023-2028) & (K Units)

Table 92. Global Genetic Engineering Drug Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Genetic Engineering Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Genetic Engineering Drug Revenue Market Share Forecast by Application (2023-2028)

Table 95. Shanghai Lansheng Guojian Pharmaceutical Basic Information, Genetic Engineering Drug Manufacturing Base, Sales Area and Its Competitors

Table 96. Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Product Offered

Table 97. Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 98. Shanghai Lansheng Guojian Pharmaceutical Main Business

Table 99. Shanghai Lansheng Guojian Pharmaceutical Latest Developments

Table 100. Biotech Pharmaceutical Basic Information, Genetic Engineering Drug Manufacturing Base, Sales Area and Its Competitors

Table 101. Biotech Pharmaceutical Genetic Engineering Drug Product Offered

Table 102. Biotech Pharmaceutical Genetic Engineering Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 103. Biotech Pharmaceutical Main Business

Table 104. Biotech Pharmaceutical Latest Developments

Table 105. Anhui Anke Biotechnology Basic Information, Genetic Engineering Drug Manufacturing Base, Sales Area and Its Competitors

Table 106. Anhui Anke Biotechnology Genetic Engineering Drug Product Offered

Table 107. Anhui Anke Biotechnology Genetic Engineering Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 108. Anhui Anke Biotechnology Main Business

Table 109. Anhui Anke Biotechnology Latest Developments

Table 110. GeneScience Pharmaceuticals Basic Information, Genetic Engineering Drug Manufacturing Base, Sales Area and Its Competitors

Table 111. GeneScience Pharmaceuticals Genetic Engineering Drug Product Offered

Table 112. GeneScience Pharmaceuticals Genetic Engineering Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 113. GeneScience Pharmaceuticals Main Business

Table 114. GeneScience Pharmaceuticals Latest Developments

Table 115. Beijing SL Pharmaceutical Basic Information, Genetic Engineering Drug Manufacturing Base, Sales Area and Its Competitors

Table 116. Beijing SL Pharmaceutical Genetic Engineering Drug Product Offered

Table 117. Beijing SL Pharmaceutical Genetic Engineering Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 118. Beijing SL Pharmaceutical Main Business

Table 119. Beijing SL Pharmaceutical Latest Developments

Table 120. Jiangsu Sihuan Bioengineering Basic Information, Genetic Engineering Drug Manufacturing Base, Sales Area and Its Competitors

Table 121. Jiangsu Sihuan Bioengineering Genetic Engineering Drug Product Offered

Table 122. Jiangsu Sihuan Bioengineering Genetic Engineering Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 123. Jiangsu Sihuan Bioengineering Main Business

Table 124. Jiangsu Sihuan Bioengineering Latest Developments

Table 125. Shenzhen Neptunus Interlong Bio-Technique Basic Information, Genetic Engineering Drug Manufacturing Base, Sales Area and Its Competitors

Table 126. Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Product Offered

Table 127. Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 128. Shenzhen Neptunus Interlong Bio-Technique Main Business

Table 129. Shenzhen Neptunus Interlong Bio-Technique Latest Developments

Table 130. 3SBio Basic Information, Genetic Engineering Drug Manufacturing Base, Sales Area and Its Competitors

Table 131. 3SBio Genetic Engineering Drug Product Offered

Table 132. 3SBio Genetic Engineering Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 133. 3SBio Main Business

Table 134. 3SBio Latest Developments

Table 135. Tonghua Dongbao Pharmaceutical Basic Information, Genetic Engineering Drug Manufacturing Base, Sales Area and Its Competitors

Table 136. Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Product Offered

Table 137. Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 138. Tonghua Dongbao Pharmaceutical Main Business

Table 139. Tonghua Dongbao Pharmaceutical Latest Developments

List of Figures

Figure 1. Picture of Genetic Engineering Drug

Figure 2. Genetic Engineering Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Genetic Engineering Drug Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Genetic Engineering Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Genetic Engineering Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Monoclonal Antibody

Figure 10. Product Picture of Recombinant Human Erythropoietin

Figure 11. Product Picture of Recombinant Human Interferon

Figure 12. Product Picture of Recombinant Human Growth Hormone

Figure 13. Product Picture of Recombinant Human Insulin

Figure 14. Global Genetic Engineering Drug Sales Market Share by Type in 2021

Figure 15. Global Genetic Engineering Drug Revenue Market Share by Type (2017-2022)

Figure 16. Genetic Engineering Drug Consumed in Medicine

Figure 17. Global Genetic Engineering Drug Market: Medicine (2017-2022) & (K Units)

Figure 18. Genetic Engineering Drug Consumed in Research

Figure 19. Global Genetic Engineering Drug Market: Research (2017-2022) & (K Units)

Figure 20. Genetic Engineering Drug Consumed in Industrial

Figure 21. Global Genetic Engineering Drug Market: Industrial (2017-2022) & (K Units)

Figure 22. Genetic Engineering Drug Consumed in Agriculture

Figure 23. Global Genetic Engineering Drug Market: Agriculture (2017-2022) & (K Units)

Figure 24. Genetic Engineering Drug Consumed in Other

Figure 25. Global Genetic Engineering Drug Market: Other (2017-2022) & (K Units)

Figure 26. Global Genetic Engineering Drug Sales Market Share by Application (2017-2022)

Figure 27. Global Genetic Engineering Drug Revenue Market Share by Application in 2021

Figure 28. Genetic Engineering Drug Revenue Market by Company in 2021 ($ Million)

Figure 29. Global Genetic Engineering Drug Revenue Market Share by Company in 2021

Figure 30. Global Genetic Engineering Drug Sales Market Share by Geographic Region (2017-2022)

Figure 31. Global Genetic Engineering Drug Revenue Market Share by Geographic Region in 2021

Figure 32. Global Genetic Engineering Drug Sales Market Share by Region (2017-2022)

Figure 33. Global Genetic Engineering Drug Revenue Market Share by Country/Region in 2021

Figure 34. Americas Genetic Engineering Drug Sales 2017-2022 (K Units)

Figure 35. Americas Genetic Engineering Drug Revenue 2017-2022 ($ Millions)

Figure 36. APAC Genetic Engineering Drug Sales 2017-2022 (K Units)

Figure 37. APAC Genetic Engineering Drug Revenue 2017-2022 ($ Millions)

Figure 38. Europe Genetic Engineering Drug Sales 2017-2022 (K Units)

Figure 39. Europe Genetic Engineering Drug Revenue 2017-2022 ($ Millions)

Figure 40. Middle East & Africa Genetic Engineering Drug Sales 2017-2022 (K Units)

Figure 41. Middle East & Africa Genetic Engineering Drug Revenue 2017-2022 ($ Millions)

Figure 42. Americas Genetic Engineering Drug Sales Market Share by Country in 2021

Figure 43. Americas Genetic Engineering Drug Revenue Market Share by Country in 2021

Figure 44. United States Genetic Engineering Drug Revenue Growth 2017-2022 ($ Millions)

Figure 45. Canada Genetic Engineering Drug Revenue Growth 2017-2022 ($ Millions)

Figure 46. Mexico Genetic Engineering Drug Revenue Growth 2017-2022 ($ Millions)

Figure 47. Brazil Genetic Engineering Drug Revenue Growth 2017-2022 ($ Millions)

Figure 48. APAC Genetic Engineering Drug Sales Market Share by Region in 2021

Figure 49. APAC Genetic Engineering Drug Revenue Market Share by Regions in 2021

Figure 50. China Genetic Engineering Drug Revenue Growth 2017-2022 ($ Millions)

Figure 51. Japan Genetic Engineering Drug Revenue Growth 2017-2022 ($ Millions)

Figure 52. South Korea Genetic Engineering Drug Revenue Growth 2017-2022 ($ Millions)

Figure 53. Southeast Asia Genetic Engineering Drug Revenue Growth 2017-2022 ($ Millions)

Figure 54. India Genetic Engineering Drug Revenue Growth 2017-2022 ($ Millions)

Figure 55. Australia Genetic Engineering Drug Revenue Growth 2017-2022 ($ Millions)

Figure 56. Europe Genetic Engineering Drug Sales Market Share by Country in 2021

Figure 57. Europe Genetic Engineering Drug Revenue Market Share by Country in 2021

Figure 58. Germany Genetic Engineering Drug Revenue Growth 2017-2022 ($ Millions)

Figure 59. France Genetic Engineering Drug Revenue Growth 2017-2022 ($ Millions)

Figure 60. UK Genetic Engineering Drug Revenue Growth 2017-2022 ($ Millions)

Figure 61. Italy Genetic Engineering Drug Revenue Growth 2017-2022 ($ Millions)

Figure 62. Russia Genetic Engineering Drug Revenue Growth 2017-2022 ($ Millions)

Figure 63. Middle East & Africa Genetic Engineering Drug Sales Market Share by Country in 2021

Figure 64. Middle East & Africa Genetic Engineering Drug Revenue Market Share by Country in 2021

Figure 65. Egypt Genetic Engineering Drug Revenue Growth 2017-2022 ($ Millions)

Figure 66. South Africa Genetic Engineering Drug Revenue Growth 2017-2022 ($ Millions)

Figure 67. Israel Genetic Engineering Drug Revenue Growth 2017-2022 ($ Millions)

Figure 68. Turkey Genetic Engineering Drug Revenue Growth 2017-2022 ($ Millions)

Figure 69. GCC Country Genetic Engineering Drug Revenue Growth 2017-2022 ($ Millions)

Figure 70. Manufacturing Cost Structure Analysis of Genetic Engineering Drug in 2021

Figure 71. Manufacturing Process Analysis of Genetic Engineering Drug

Figure 72. Industry Chain Structure of Genetic Engineering Drug

Figure 73. Channels of Distribution

Figure 74. Distributors Profiles